William Forbes
Directeur/Membre du Conseil chez BEYOND AIR, INC.
Fortune : 341 786 $ au 30/06/2024
Profil
William P.
Forbes was the founder of Vivelix Pharmaceuticals, Ltd.
(founded in 2016) where he held the title of President & Chief Executive Officer.
He currently holds the position of Independent Director at Beyond Air, Inc. (since 2018), Director at Beyond Air Ltd.
(since 2018), Director at Hallux, Inc. (since 2018), and Chief Development Officer & Executive VP at Heron Therapeutics, Inc. (starting in 2023).
In his former positions, he served as President-Medical, Research & Development at Salix Pharmaceuticals Ltd.
(from 2005 to 2015), VP, Clinical Development & Regulator Affairs at Metabasis Therapeutics, Inc. (from 2002 to 2004), Group Leader at Otsuka America Pharmaceutical, Inc., and Senior Clinical Research Scientist at Glaxo, Inc. He also served as Chief Development Officer at Trevi Therapeutics, Inc. (from 2021 to 2022).
Dr. Forbes obtained a doctorate degree from Creighton University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HERON THERAPEUTICS INC
0,06% | 06/06/2024 | 95 374 ( 0,06% ) | 333 809 $ | 30/06/2024 |
BEYOND AIR, INC.
0,03% | 20/06/2024 | 14 855 ( 0,03% ) | 7 977 $ | 30/06/2024 |
Postes actifs de William Forbes
| Sociétés | Poste | Début |
|---|---|---|
| BEYOND AIR, INC. | Directeur/Membre du Conseil | 13/08/2018 |
| HERON THERAPEUTICS, INC. | Corporate Officer/Principal | 06/06/2023 |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Directeur/Membre du Conseil | 01/01/2018 |
Hallux, Inc.
 Hallux, Inc. Pharmaceuticals: MajorHealth Technology Hallux, Inc. provides pharmaceutical services. It develops a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis. The company was founded by Mark T. Taylor, Jay Edward Birnbaum, Hendrik Arend Kroon and Robert Orr in 2012 and is headquartered in Laguna Hills, CA. | Directeur/Membre du Conseil | 01/11/2018 |
Anciens postes connus de William Forbes
| Sociétés | Poste | Fin |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2022 |
| SALIX PHARMACEUTICALS, LTD. | Directeur Technique/Scientifique/R&D | 01/06/2015 |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Conseiller Juridique Général | 01/01/2004 |
Vivelix Pharmaceuticals, Ltd.
 Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Vivelix Pharmaceuticals, Ltd. manufactures and sells pharmaceutical products. The private company is based in Hamilton, BM. and has subsidiaries in the United States. The Bermudian company was founded by William P. Forbes. | Directeur Général | - |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - |
Formation de William Forbes
| Creighton University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| TREVI THERAPEUTICS, INC. | Health Technology |
| BEYOND AIR, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
| Glaxo, Inc. | |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Health Technology |
Hallux, Inc.
Hallux, Inc. Pharmaceuticals: MajorHealth Technology Hallux, Inc. provides pharmaceutical services. It develops a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis. The company was founded by Mark T. Taylor, Jay Edward Birnbaum, Hendrik Arend Kroon and Robert Orr in 2012 and is headquartered in Laguna Hills, CA. | Health Technology |
Vivelix Pharmaceuticals, Ltd.
Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Vivelix Pharmaceuticals, Ltd. manufactures and sells pharmaceutical products. The private company is based in Hamilton, BM. and has subsidiaries in the United States. The Bermudian company was founded by William P. Forbes. | Health Technology |
